ClassAction.org Newsletter Archive

The bulk of our latest issue takes a look at companies accused of promoting products that don’t live up to their advertised claims.

In this issue, we’ll cover a couple of new and ongoing investigations into foreign transaction fees and Fiat Chrysler engine problems, plus a lawsuit that’s already been filed over HP’s Instant Ink program.

The bulk of our latest issue is focused on settlements involving Kellogg’s cereals and Canidae pet food, but that’s not all we have for you this week.

In our latest issue, we’ll cover everything from the products you use for immune support and sun protection to leaking sunroofs and potentially mislabeled cosmetics.

The theme of this week’s issue is sustainable products. Whether you’re concerned about the ethical treatment of animals or the recyclability of single-use plastics, product sustainability has become a major selling point for the environmentally conscious.

The top stories in the latest edition of ClassAction.org’s newsletter revolve around the ongoing investigation into haircare products that can cause hair loss and scalp irritation, and the slew of problems iPhone users have reported.

In this issue, we’ll open with a new investigation involving military bases whose use of firefighting foam in training exercises may have contaminated local groundwater.

In our top story this week, ParkMobile, the company that touts its app as “the leading provider of parking solutions in the U.S.,” is facing a lawsuit over a recent data breach that has placed many users’ personal information “in the hands of criminals.”

If you buy vanilla almond milk products from Almond Breeze, you came to the right place, as a recent settlement means that you may be able to get some of your money back.

Our premier story in this week’s issue deals with a recent data breach involving GEICO that may have led to the filing of fake unemployment claims.

In our top story for this week, we’re taking a look at lawsuits that have been filed on behalf of people who developed cancer after taking recalled batches of the blood pressure drug valsartan.

This week, we have several new lawsuits that we need to delve into. First up, we have a case filed against Peloton over safety concerns surrounding its Tread+ treadmill.